eLearning

DIA eLearning is Internet-based courseware that can be accessed 24 hours a day, 7 days a week. Modules do not have to be taken in one sitting; users can start/stop at any time and begin where they left off. After a module is completed, users will be able to review the module for one year from the date of purchase. Continuing Education credits are offered for some modules. To obtain Continuing Education credit (if applicable) for a module, you must receive a passing score on the exam and complete the evaluation within one month of completing the module. 

eLearning Catalog







How to Access eLearning Modules

DIA has partnered with Zenosis by Intellego to provide the following eLearning modules:

Variations to Marketing Authorisation in Europe

Registration of Monoclonal Antibodies

The ANDA: Requirements for Obtaining FDA Approval for a Generic Product in the USA

Pharmacokinetics and Pharmacodynamics in Drug Registration

DIA has partnered with Thomson Reuters to provide the following IDRAC® eLearning  modules:

Access to Unapproved Drugs through Compassionate Use

Regulatory Requirements for the Conduct of Clinical Trials in Europe

Orphan Drugs in Europe, USA and Japan

Regulatory Requirements for the Submission of Investigational New Drug Applications in the USA (INDs)

Meeting Opportunities with Regulatory Agencies

Introduction to the European Union Institutions and Regulatory Authority

Introduction to US Institutions and Regulatory Authority (FDA)

Introduction to Japanese Institutions and Regulatory Authorities

Overview of the CTD and the eCTD

Introduction to the International Conference on Harmonization (ICH)

The Regulatory Development Cycle of a Drug

Basics of Pharmacovigilance

Basics of Clinical Trials

How to Register Medicinal Products through the Centralized Procedure

How to Register Medicinal Products through the Mutual Recognition Procedure

How to Maintain Marketing Approvals in Europe for Centrally Authorized Products

How to Register a New Drug in the USA

How to Register Medicinal Products through the Decentralized Procedure



DIA has partnered with Kaplan EduNeering to provide the following eLearning modules:

Clinical Pharmaceutical eLearning Program

Tour of FDA Tour of Health Canada Tour of Health Europe Aspects of Regulatory History Bioresearch Monitoring Program (BIMO): Introduction Clinical Development Process: Investigational Product, Plan and Data Management Clinical Trial Audits and Consequences of Noncompliance Drug Safety & Adverse Event Reporting Ethical Review Boards Ethics as the Foundation to Clinical Research European Union Clinical Trials Directive Good Clinical Practices (GCPs) for New Product Investigations Good Laboratory Practices (GLPs) GxPs HIPAA-The Impact on Clinical Research Investigational Product Development Laboratory Specimens for Clinical Research Overview of the Clinical Research Process Protection of Human Subjects in Clinical Trials Selecting and Managing Clinical Contract Research Organizations (CROs) DIA's Informed Consent

Clinical Medical Device eLearning Program

Tour of FDA Tour of Health Canada Tour of Health Europe Aspects of Regulatory History Bioresearch Monitoring Program (BIMO): Introduction Clinical Development Process: Investigational Product, Plan and Data Management Ethical Review Boards Ethics as the Foundation to Clinical Research European Union Clinical Trials Directive Good Clinical Practices (GCPs) for New Product Investigations Good Laboratory Practices (GLPs) GxPs HIPAA-The Impact on Clinical Research ISO 14155: Obligations of Sponsors and Monitors for Medical Device Trials Laboratory Specimens for Clinical Research Medical Device Safety Reporting Overview of the Clinical Research Process Protection of Human Subjects in Clinical Trials Selecting and Managing Clinical Contract Research Organizations (CROs) DIA's Informed Consent

GMP Pharmaceutical eLearning Program

GxPs Orientation to GMP Compliance Biotechnology: An Overview of Compliance Considerations GMPs for API Bulk Manufacturers GMP Principles of SOPs Principles of Good Documentation Part 11-Electronic Records and Electronic Signatures Key Concepts of Process Validation Change Control Awareness of FDA Inspections for Pharmaceutical Manufacturers GMP Updates-Enforcement Changes at the New FDA Introduction to GMPs Understanding Postapproval Changes

Validation and Part 11 Compliance

Computerized Systems Inspections in the Pharmaceutical Industry Computerized Systems Inspections in the Medical Device Industry Part 11: Electronic Records and Electronic Signatures Part 11: Electronic Records and Signatures-Application

Basics of the PhRMA Code Basics of the AdvaMed Code Eucomed Guidelines on Interactions with Healthcare Professionals Introduction to Medical Device Compliance Global Anti-bribery Foreign Corrupt Practices Act